Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Trulicity
Trulicity
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
Fierce Pharma
Mon, 06/10/19 - 09:27 am
Eli Lilly
ADA
diabetes
heart attack
stroke
Trulicity
Novo Nordisk
semaglutide
In a blockbuster franchise race, Novo’s Trulicity rival scores more promising late-stage diabetes data
Endpoints
Mon, 03/4/19 - 10:20 am
Novo Nordisk
Trulicity
Ozempic
Eli Lilly
diabetes
7 drugs that raised eyebrows in Q3
Biopharma Dive
Thu, 11/15/18 - 11:50 pm
Sanofi
Dupixent
Roche
Herceptin
AbbVie
Humira
Regeneron
Repatha
Clovis Oncology
Rubraca
GSK
Shingrix
Eli Lilly
Trulicity
Despite Trulicity success, Lilly can't escape diabetes concerns
Biopharma Dive
Wed, 11/7/18 - 12:00 am
Eli Lilly
diabetes
earnings
Trulicity
Eli Lilly touts MACE win for diabetes blockbuster Trulicity — a 'nice positive'
Endpoints
Mon, 11/5/18 - 11:54 am
Eli Lilly
Trulicity
diabetes
Eli Lilly ushers up-and-coming GIP/GLP-1 drug into PhIII as Novo Nordisk rival wows with impressive results
Endpoints
Thu, 10/4/18 - 11:58 am
Eli Lilly
diabetes
Novo Nordisk
Ozempic
LY3298176
Trulicity
Trulicity’s turn to show a cardiovascular benefit
EP Vantage
Tue, 09/4/18 - 05:04 pm
Trulicity
Eli Lilly
Repurposing a GLP-1 diabetes drug to slow Parkinson’s disease
Fierce Biotech
Tue, 07/24/18 - 10:32 am
diabetes
Parkinson's Disease
GLP-1 agonist
AstraZeneca
Byetta
Bydureon
Novo Nordisk
Victoza
Ozempic
Eli Lilly
Trulicity
Peptron
ADA: Lilly's Trulicity bests Novo's Victoza, AZ's Bydureon in real-world study
Fierce Pharma
Mon, 06/25/18 - 09:07 pm
Eli Lilly
Trulicity
diabetes
Novo Nordisk
Victoza
AstraZeneca
Bydureon
ADA
5 Biggest Blockbuster Diabetes Drugs of the Future
Motley Fool
Sun, 06/24/18 - 10:04 am
Eli Lilly
Trulicity
Novo Nordisk
Ozempic
Boehringer Ingelheim
Jardiance
Tresiba
NovoRapid
Novo reveals more Ozempic data on change in body weight by baseline BMI
Yahoo/Reuters
Sat, 06/23/18 - 01:08 pm
Novo Nordisk
diabetes
BMI
Ozempic
Eli Lilly
Trulicity
Lilly touts Ph3 data for once-weekly Type II diabetes medication
Drug Delivery Business News
Mon, 02/26/18 - 07:27 pm
Eli Lilly
diabetes
clinical trials
Trulicity
In a turf war with Eli Lilly, Novo Nordisk steps off with positive PhIII for its challenging oral GLP-1 drug
Endpoints
Thu, 02/22/18 - 09:12 am
Novo Nordisk
Eli Lilly
diabetes
clinical trials
semaglutide
Trulicity
Bring on Novo Nordisk’s semaglutide, Eli Lilly says. We’re ready
Fierce Pharma
Mon, 02/12/18 - 11:00 am
Novo Nordisk
semaglutide
Eli Lilly
Ozempic
Trulicity
Lilly's 2018 forecast beats on strength of new drugs
Yahoo/Reuters
Wed, 12/13/17 - 09:41 am
Eli Lilly
Trulicity
Taltz
Novo's experimental diabetes drug likely to compete with Trulicity
Medical Marketing and Media
Tue, 10/17/17 - 08:29 pm
Novo Nordisk
diabetes
Trulicity
semaglutide
Diabetes drugs must prove their value to payers, analysts say
Medical Marketing and Media
Tue, 08/22/17 - 06:48 pm
diabetes
payers
Novo Nordisk
semaglutide
Eli Lilly
Trulicity
Novo’s diabetes medication Victoza keeps growing, despite Lilly’s market-share creep
Fierce Pharma
Thu, 05/4/17 - 10:08 am
Novo Nordisk
Victoza
diabetes
Eli Lilly
Trulicity
Eli Lilly wins label expansion for Trulicity injection with basal insulin
Endpoints
Wed, 02/8/17 - 09:39 pm
Eli Lilly
Trulicity
basal insulin
diabetes
Diabetes sales rocket toward $60B, with Novo and Lilly's GLP-1s first in line for growth
Fierce Pharma
Mon, 07/11/16 - 09:15 am
diabetes
Novo Nordisk
Eli Lilly
GLP-1 agonist
Victoza
Trulicity
Pages
« first
‹ previous
1
2
3
next ›
last »